By Patrick D Hahn
Hot on the heels of the publication of David Healy’s Shipwreck of the Singular comes a paper in Neuropsychopharmacology by Elan Cohen and seven of his colleagues which demonstrates why Shipwreck was needed in the first place.
Seven of the eight authors of the paper are drug company employees. The subject of the paper is the “mitigation” of the placebo response in placebo-controlled randomized clinical trials.
As Dr. Healy points out in Shipwreck, the placebo-controlled randomized clinical trial once was held up as a shield to protect us from useless or dangerous medicines but in fact has turned into a vehicle to deliver adverse consequences with impunity…